In vitro and in vivo targeted delivery of IL-10 interfering RNA by JC virus-like particles

Journal of Biomedical Science

Volumn 17, Issue 1, 2010, Pages

  Chou, Meng Ing ^a   Hsieh, Yu Fan ^a   Wang, Meilin ^a   Chang, Jinghua Tsai ^a   Chang, Deching ^b   Zouali, Moncef ^c,d   Tsay, Gregory J ^a,e  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^c HÔPITAL LARIBOISIÈRE   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; INTERLEUKIN 10; PROTEIN VP1; SHORT HAIRPIN RNA; TUMOR NECROSIS FACTOR ALPHA; CAPSID PROTEIN; COMPLEMENTARY DNA; SMALL INTERFERING RNA; VP1 PROTEIN, POLYOMAVIRUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; JC VIRUS; MOUSE; NONHUMAN; OSMOTIC STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEPTIC SHOCK; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID; VIRUS LIKE AGENT; VIRUS PURIFICATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL LINE; DRUG ANTAGONISM; GENE EXPRESSION; GENE VECTOR; GENETICS; NUCLEOTIDE SEQUENCE; VIRION;

JC POLYOMAVIRUS; MIRIDAE; MURINAE; MUS;

ANIMALS; BASE SEQUENCE; CAPSID PROTEINS; CELL LINE; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION; GENETIC VECTORS; INTERLEUKIN-10; JC VIRUS; MICE; MICE, INBRED BALB C; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA; VIRION;

EID: 77954333700     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-51     Document Type: Article

References (23)

1. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. J Soutschek A Akinc B Bramlage K Charisse R Constien M Donoghue S Elbashir A Geick P Hadwiger J Harborth M John V Kesavan G Lavine RK Pandey T Racie KG Rajeev I Rohl I Toudjarska G Wang S Wuschko D Bumcrot V Koteliansky S Limmer M Manoharan HP Vornlocher, Nature 2004 432 7014 173 178 10.1038/nature03121 15538359
2. The prospect of silencing disease using RNA interference. P Shankar N Manjunath J Lieberman, Jama 2005 293 11 1367 1373 10.1001/jama.293.11.1367 15769970
3. Delivery of RNA interference therapeutics using polycation-based nanoparticles. KA Howard, Adv Drug Deliv Rev 2009 61 710 720 10.1016/j.addr.2009.04.001 19356738
4. Self-assembly of the JC virus major capsid protein, VP1, expressed in insect cells. D Chang CY Fung WC Ou PC Chao SY Li M Wang YL Huang TY Tzeng RT Tsai, J Gen Virol 1997 78 Pt 6 1435 1439 9191941
5. Inhibition of simian virus 40 large tumor antigen expression in human fetal glial cells by an antisense oligodeoxynucleotide delivered by the JC virus-like particle. M Wang TH Tsou LS Chen WC Ou PL Chen CF Chang CY Fung D Chang, Hum Gene Ther 2004 15 11 1077 1090 10.1089/hum.2004.15.1077 15610608
6. Packaging of small molecules into VP1-virus-like particles of the human polyomavirus JC virus. C Goldmann N Stolte T Nisslein G Hunsmann W Luke H Petry, J Virol Methods 2000 90 1 85 90 10.1016/S0166-0934(00)00226-3 11011084
7. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon-gamma-secreting cells in the peripheral blood. E Hagiwara MF Gourley S Lee DK Klinman, Arthritis Rheum 1996 39 3 379 385 10.1002/art.1780390305 8607886
8. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. L Llorente Y Richaud-Patin R Fior J Alcocer-Varela J Wijdenes BM Fourrier P Galanaud D Emilie, Arthritis Rheum 1994 37 11 1647 1655 10.1002/art.1780371114 7980676
9. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. L Llorente Y Richaud-Patin C Garcia-Padilla E Claret J Jakez-Ocampo MH Cardiel J Alcocer-Varela L Grangeot-Keros D Alarcon-Segovia J Wijdenes P Galanaud D Emilie, Arthritis Rheum 2000 43 8 1790 1800 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0. CO;2-2 10943869
10. IL-10 regulates murine lupus. Z Yin G Bahtiyar N Zhang L Liu P Zhu ME Robert J McNiff MP Madaio J Craft, J Immunol 2002 169 4 2148 2155 12165544
11. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. H Ishida T Muchamuel S Sakaguchi S Andrade S Menon M Howard, J Exp Med 1994 179 1 305 310 10.1084/jem.179.1.305 8270873
12. Disulfide bonds stabilize JC virus capsid-like structure by protecting calcium ions from chelation. PL Chen M Wang WC Ou CK Lii LS Chen D Chang, FEBS Lett 2001 500 3 109 113 10.1016/S0014-5793(01)02598-4 11445066
13. An economic and efficient method of RNAi vector constructions. JT Chang, Anal Biochem 2004 334 1 199 200 10.1016/j.ab.2004.07.018 15464970
14. The major capsid protein, VP1, of human JC virus expressed in Escherichia coli is able to self-assemble into a capsid-like particle and deliver exogenous DNA into human kidney cells. WC Ou M Wang CY Fung RT Tsai PC Chao TH Hseu D Chang, J Gen Virol 1999 80 Pt 1 39 46 9934681
15. Efficient gene transfer using the human JC virus-like particle that inhibits human colon adenocarcinoma growth in a nude mouse model. LS Chen M Wang WC Ou CY Fung PL Chen CF Chang WS Huang JY Wang PY Lin D Chang, Gene Ther DOI: gt. 2010.50 20410928
16. Broad distribution of the JC virus receptor contrasts with a marked cellular restriction of virus replication. S Suzuki H Sawa R Komagome Y Orba M Yamada Y Okada Y Ishida H Nishihara S Tanaka K Nagashima, Virology 2001 286 1 100 112 10.1006/viro.2001.0972 11448163
17. Interleukin-10. KW Moore A O'Garra R de Waal Malefyt P Vieira TR Mosmann, Annu Rev Immunol 1993 11 165 190 10.1146/annurev.iy.11.040193.001121 8386517
18. In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A. P Durez D Abramowicz C Gerard M Van Mechelen Z Amraoui C Dubois O Leo T Velu M Goldman, J Exp Med 1993 177 2 551 555 10.1084/jem.177.2.551 8426125
19. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. A Marchant C Bruyns P Vandenabeele M Ducarme C Gerard A Delvaux D De Groote D Abramowicz T Velu M Goldman, Eur J Immunol 1994 24 5 1167 1171 10.1002/eji.1830240524 8181527
20. Interleukin 10 protects mice from lethal endotoxemia. M Howard T Muchamuel S Andrade S Menon, J Exp Med 1993 177 4 1205 1208 10.1084/jem.177.4. 1205 8459215
21. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. DJ Berg R Kuhn K Rajewsky W Muller S Menon N Davidson G Grunig D Rennick, J Clin Invest 1995 96 5 2339 2347 10.1172/JCI118290 7593621
22. Proinflammatory effects of IL-10 during human endotoxemia. FN Lauw D Pajkrt CE Hack M Kurimoto SJ van Deventer T van der Poll, J Immunol 2000 165 5 2783 2789 10946310
23. Proinflammatory effects of exogenously administered IL-10 in experimental autoimmune orchitis. T Kaneko M Itoh Y Nakamura A Iimura S Hayashi K Takahashi F Stivala K Bendtzen F Nicoletti, Cytokine 2003 22 1-2 50 53 10.1016/S1043-4666(03)00103-0 12946105